ibandronic acid has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilera Pradenas, N; Pilon, M; Pitot, C; Ranji, P; Rauthan, M | 1 |
1 other study(ies) available for ibandronic acid and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
The mitochondrial unfolded protein response activator ATFS-1 protects cells from inhibition of the mevalonate pathway.
Topics: Alleles; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cholesterol; Diphosphonates; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ibandronic Acid; Indoles; Male; Mevalonic Acid; Mice; Mitochondria; Mutagenesis; Mutation; NIH 3T3 Cells; Oxidative Stress; RNA Interference; Sequence Analysis, DNA; Transcription Factors; Unfolded Protein Response | 2013 |